loader2
Partner With Us NRI

Bliss GVS Pharma Ltd share Price Today

Company details

103.05
106.50
72.00
149.60
6M Return -28.70%
1Y Return 42.95%
Mkt Cap.(Cr) 1,092.45
Volume 276,836
Div Yield 0.47%
OI
-
OI Chg %
-
Volume 276,836

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Key Highlights 

  • Revenue from Operation Rs 30,745.88 Lakhs
  • EBITDA Rs  5,869.56 Lakhs 19%
  • Revenue from Operation Rs  23,284.38 Lakhs
  • EBITDA Rs  4,498.07 Lakhs 19%
  • Other Income Rs 1388.20 Lakhs
  • Other Income Rs 1013.00 Lakhs
  • PBT Rs  6381.44 Lakhs 20%
  • PBT Rs 4,667.44 Lakh  19%
  • PAT Rs 4,638.54 Lakhs 14%
  • PAT Rs  3,588.33 Lakhs 15%

 

 

Result PDF

View Other Company Results

Bliss GVS Pharma Ltd shares SWOT Analysis

Strengths (6)

  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year
  • Company with Low Debt
  • Annual Net Profits improving for last 2 years

Weakness (4)

  • Declining Revenue every quarter for the past 2 quarters
  • Declining profits every quarter for the past 2 quarters
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Threats (2)

  • Increasing Trend in Non-Core Income
  • RSI indicating price weakness

Resistance and support

R1 106.2
R2 108.1
R3 109.7
Pivot

104.63

S1 102.8
S2 101.2
S3 99.3
EMA SMA
110.1
113.3
114.5
110.2
111.5
112.8
117.9
112.1
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-11-08 115.4 610465 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2023-11-08 115.47 610465 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-11-07 110.3 1174929 NSE
Name Category Shares
Narsimha Shibroor Kamath PROMOTER 30.53%
Vibha Gagan Sharma PROMOTER 2.36%
Shruti Vishal Rao PROMOTER 2.02%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Bliss GVS Pharma Ltd Stocks COMPARISON

Financials( in Cr) Bliss GVS Pharma Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 104.35 1,464.90 1,479.45 4,392.10 1,052.95
% Change -0.95 -0.08 0.05 3.22 -0.52
Mcap Cr 1,092.45 351,478.58 119,445.91 116,596.64 105,951.41
Revenue TTM Cr 751.59 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 76.73 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 11.40 35.12 28.05 72.85 27.42
1 Year Return 42.95 51.26 54.71 26.29 105.63
ROCE 12.14 16.79 14.76 19.30 16.25
ROE 9.01 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 883.90 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 39,096.78 -22,281.88
LAST 3M 109,317.46 -33,313.91
LAST 6M 173,877.04 36,325.60
LAST 12M 271,641.54 124,224.97

Bliss GVS Pharma Ltd Information

Stock PE (TTM)
11.4
Promoter Holding
34.97%
Book Value
92.3853
ROCE
12.14%
ROE
9.01%
Description
  • Bliss GVS Pharma Limited is a company that operates in the manufacturing of pharmaceutical products and has a market capitalization of Rs 1,038.74 Crores on 24th August '2021. In 1984, it became a corporation as a private limited company by the name “Bliss Chemicals & Pharmaceuticals India Limited”, and the company commenced its business in the year 1985. At the end of March 2020, it registered combined revenue of Rs 689.31 Crores. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 506197 and scrip code BLISSGVS. As of 24th August '2021, Bliss GVS Pharma Limited is trading at Rs. 100.50.

    The company has four wholly owned subsidiaries and three step-down subsidiaries as of 31st March 2020. BGPL is developing on its global expertise and gaining a leadership position in anti-malarial, anti-fungal, dermatological, anti-inflammatory branded formulations. The plant is well equipped to manufacture various dosage forms like Tablets, Capsules, Dry Syrups, and Sachets, etc., with a capacity of ~420 MN per annum. Bliss GVS Pharma Limited has a strong geographical foothold presence in more than 60 countries from Africa to North America to Southeast Asia with more than 250 brand formulations. In FY20, the geographical revenue mix from sub-Saharan Africa was 76%, followed by India contributing 21% and the Rest of the World at 3%. It has 663 permanent employees on the rolls as of 31st March 2020. The promoters and promoter’s group holds 41.60% of the stake within the company, and the rest, 58.40%, is owned by the others (public shareholding).

    In June 2021, total sales were Rs 140.93 Crores, up 16.50% from Rs 120.97 Crores in June 2020. The quarterly Net Profit in June 2021 was Rs. 21.66 Crores, up 26.67% from Rs. 17.10 Crores in June 2020. In June 2021, operating profit was Rs. 117.55 Crores, up 8.04% from Rs. 108.81 Crores in June 2020. From Rs. 1.66 in June 2020, Bliss GVS Pharma Limited’s EPS has risen to Rs. 2.10 in June 2021. From 13% in March 2019, Bliss GVS Pharma Limited’s return on capital employed has increased to 14.36% in March 2020.

Registered Address

102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072

Tel : 91-22-42160000
Email : cs:blissgvs.com; info:blissgvs.com
Website : http://www.blissgvs.com
Registrar

Universal Capital Sec. Pvt Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 506197
NSE Code : BLISSGVS
Book Closure Date (Month) : Jul
BSE Group : B
ISIN : INE416D01022

FAQ’s on Bliss GVS Pharma Ltd Shares

You can buy Bliss GVS Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Bliss GVS Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 28, 2024 03:58 PM the closing price of Bliss GVS Pharma Ltd was Rs.104.35.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 28, 2024 03:58 PM, the market cap of Bliss GVS Pharma Ltd stood at Rs. 1,092.45.

The latest PE ratio of Bliss GVS Pharma Ltd as of May 28, 2024 03:58 PM is 11.40

The latest PB ratio of Bliss GVS Pharma Ltd as of May 28, 2024 03:58 PM is 0.89

The 52-week high of Bliss GVS Pharma Ltd share price is Rs. 149.60 while the 52-week low is Rs. 72.00

Download App

Download Our App

Play Store App Store
market app